Willis Towers Watson Valuation
Is WTY undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of WTY when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: WTY (€294) is trading above our estimate of fair value (€202.6)
Significantly Below Fair Value: WTY is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for WTY?
Key metric: As WTY is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is WTY's PS Ratio? | |
|---|---|
| PS Ratio | 3.2x |
| Sales | US$9.81b |
| Market Cap | US$31.50b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 3.7x |
| Enterprise Value/EBITDA | 14x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does WTY's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.9x | ||
HNR1 Hannover Rück | 1.1x | 2.5% | €28.8b |
TLX Talanx | 0.4x | 8.5% | €20.1b |
MUV2 Münchener Rückversicherungs-Gesellschaft in München | 1x | 6.9% | €62.6b |
ALV Allianz | 1.1x | 9.2% | €110.1b |
WTY Willis Towers Watson | 3.2x | 1.0% | €31.5b |
Price-To-Sales vs Peers: WTY is expensive based on its Price-To-Sales Ratio (3.2x) compared to the peer average (0.9x).
Price to Sales Ratio vs Industry
How does WTY's PS Ratio compare vs other companies in the European Insurance Industry?
| 2 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| 2 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Sales vs Industry: WTY is expensive based on its Price-To-Sales Ratio (3.2x) compared to the European Insurance industry average (1x).
Price to Sales Ratio vs Fair Ratio
What is WTY's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 3.2x |
| Fair PS Ratio | 1.1x |
Price-To-Sales vs Fair Ratio: WTY is expensive based on its Price-To-Sales Ratio (3.2x) compared to the estimated Fair Price-To-Sales Ratio (1.1x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €294.00 | €315.65 +7.4% | 9.0% | €350.99 | €249.21 | n/a | 19 |
| Nov ’25 | €276.00 | €299.72 +8.6% | 8.0% | €340.51 | €241.77 | n/a | 19 |
| Oct ’25 | €264.00 | €279.12 +5.7% | 7.6% | €329.74 | €228.56 | n/a | 19 |
| Sep ’25 | €262.00 | €278.81 +6.4% | 6.3% | €302.20 | €228.23 | n/a | 19 |
| Aug ’25 | €260.00 | €285.45 +9.8% | 6.4% | €309.88 | €234.03 | n/a | 19 |
| Jul ’25 | €242.00 | €279.43 +15.5% | 6.2% | €307.29 | €236.30 | n/a | 19 |
| Jun ’25 | €230.00 | €276.05 +20.0% | 6.2% | €304.03 | €233.80 | n/a | 19 |
| May ’25 | €234.00 | €277.34 +18.5% | 6.6% | €306.86 | €235.97 | n/a | 19 |
| Apr ’25 | €252.00 | €271.93 +7.9% | 9.2% | €306.30 | €219.72 | n/a | 19 |
| Mar ’25 | €250.00 | €267.94 +7.2% | 8.8% | €295.30 | €217.78 | n/a | 19 |
| Feb ’25 | €226.00 | €238.84 +5.7% | 10.1% | €290.40 | €197.59 | n/a | 18 |
| Jan ’25 | €214.00 | €235.29 +10.0% | 8.0% | €268.75 | €198.72 | n/a | 17 |
| Dec ’24 | €224.00 | €235.29 +5.0% | 8.0% | €268.75 | €198.72 | n/a | 17 |
| Nov ’24 | €220.00 | €235.29 +7.0% | 8.0% | €268.75 | €198.72 | €276.00 | 17 |
| Oct ’24 | €200.00 | €223.74 +11.9% | 7.2% | €248.15 | €191.96 | €264.00 | 17 |
| Sep ’24 | €190.00 | €221.15 +16.4% | 7.5% | €249.59 | €189.50 | €262.00 | 17 |
| Aug ’24 | €188.00 | €222.64 +18.4% | 7.5% | €259.49 | €198.49 | €260.00 | 17 |
| Jul ’24 | €212.00 | €236.22 +11.4% | 6.9% | €261.12 | €210.73 | €242.00 | 17 |
| Jun ’24 | €200.00 | €241.64 +20.8% | 7.1% | €266.67 | €215.21 | €230.00 | 16 |
| May ’24 | €204.00 | €238.97 +17.1% | 7.5% | €275.27 | €209.65 | €234.00 | 17 |
| Apr ’24 | €208.00 | €250.56 +20.5% | 7.7% | €284.97 | €217.26 | €252.00 | 17 |
| Mar ’24 | €220.00 | €250.43 +13.8% | 8.1% | €285.64 | €217.76 | €250.00 | 17 |
| Feb ’24 | €226.00 | €236.57 +4.7% | 8.8% | €275.82 | €207.55 | €226.00 | 17 |
| Jan ’24 | €228.00 | €227.98 -0.008% | 10.3% | €284.21 | €197.63 | €214.00 | 16 |
| Dec ’23 | €228.00 | €231.71 +1.6% | 8.5% | €279.50 | €203.81 | €224.00 | 16 |
| Nov ’23 | €216.00 | €240.89 +11.5% | 7.9% | €291.57 | €212.60 | €220.00 | 16 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Arch Capital Group
US$36.3b
Provides insurance, reinsurance, and mortgage insurance products worldwide.
RSK
US$91.14
7D
-2.5%
1Y
18.4%
Sagicor Financial
CA$838.1m
Provides insurance products and related financial services in Jamaica, Barbados, Trinidad, Tobago, other Caribbean region, and the United States.
3RQ
CA$4.08
7D
3.0%
1Y
5.2%
HCI Group
US$1.1b
Engages in the property and casualty insurance, insurance management, reinsurance, real estate, and information technology businesses in Florida.
0H5
US$104.00
7D
-2.8%
1Y
36.8%